Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

Published:1998-10 Issue:9138 Volume:352 Page:1413-1418
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cunningham David,Pyrhönen Seppo,James Roger D,Punt Cornelis JA,Hickish Tamas F,Heikkila Reino,Johannesen Tom B,Starkhammar Hans,Topham Clare A,Awad Lucile,Jacques Christian,Herait Patrice

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. Cancer of the colon;Cohen,1997

2. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate;J Clin Oncol,1992

3. Tumor response and stabilization rates are worthwhile surrogate endpoints in metastatic colorectal cancer. analysis of data in 455 5FU-resistant patients treated with CPT-11;Fages;Proc ASCO,1997

4. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer;Glimelius;Cancer,1994

5. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial;J Clin Oncol,1992

Cited by 1123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

2. Post‐diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta‐analysis;International Journal of Cancer;2024-05

3. Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment;Annals of Coloproctology;2024-04-30

4. Roles of breast cancer resistance protein and organic anion transporting polypeptide 2B1 in gastrointestinal toxicity induced by SN-38 under inflammatory conditions;Toxicology Letters;2024-04

5. Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1;Clinical Pharmacokinetics;2023-09-16